AgenT

AgenT
AgenT
AgenT develops the first blood diagnosis to detect Alzheimer’s earlier, when it could be prevented. AgenT’s blood test uses both Machine Learning and multiomics biomarkers signals to detect Alzheimer’s from the silent phase.
Paris
Biotechnology, Health Care, Health Diagnostics, Life Science, Neuroscience
Between €100K-€500K
2018
https://www.agent-biotech.com/

Articles about AgenT:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as AgenT? We’re happy to assist you with our Startup Sourcing service.